National Research Corp
(NRC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 35,021 | 35,313 | 38,001 | 37,945 | 36,161 |
| Cost of Goods | 13,422 | 13,856 | 13,793 | 14,633 | 13,309 |
| Gross Profit | 21,599 | 21,457 | 24,208 | 23,312 | 22,852 |
| Operating Expenses | 13,156 | 13,553 | 13,292 | 13,990 | 13,796 |
| Operating Income | 8,865 | 8,760 | 11,709 | 9,955 | 9,365 |
| Interest Expense | 555 | 605 | 269 | 160 | 192 |
| Other Income | 14 | 39 | 28 | 244 | 271 |
| Pre-tax Income | 8,324 | 8,194 | 11,468 | 10,039 | 9,444 |
| Income Tax | 2,149 | 1,835 | 2,610 | 2,163 | 2,171 |
| Net Income Continuous | 6,175 | 6,359 | 8,858 | 7,876 | 7,273 |
| Net Income | $6,175 | $6,359 | $8,858 | $7,876 | $7,273 |
| EPS Basic Total Ops | 0.26 | 0.27 | 0.36 | 0.32 | 0.30 |
| EPS Basic Continuous Ops | 0.26 | 0.27 | 0.36 | 0.32 | 0.30 |
| EPS Diluted Total Ops | 0.26 | 0.27 | 0.36 | 0.32 | 0.29 |
| EPS Diluted Continuous Ops | 0.26 | 0.27 | 0.36 | 0.32 | 0.29 |
| EPS Diluted Before Non-Recurring Items | 0.26 | 0.27 | 0.36 | N/A | N/A |
| EBITDA(a) | $10,387 | $10,216 | $13,139 | $11,509 | $10,886 |